Artemis Medicare reports strong Q3 growth: revenue up 17%, net profit up 8%

Artemis Medicare reports strong Q3 growth: revenue up 17%, net profit up 8%

By: IPP Bureau

Last updated : February 03, 2026 11:55 am



Nine-month revenue grew 17.5% to Rs 76,277 lakh, EBITDA climbed to Rs 15,981 lakh, and net profit reached Rs 8,200 lakh


Artemis Medicare Services has announced robust financial results for the third quarter of FY2025-26, underscoring its growing footprint in India’s healthcare sector, driven by high-acuity treatments and rising international patient inflows.
 
Consolidated revenue from operations rose 17.2% year-on-year to Rs 27,235 lakh while EBITDA climbed 12.5% to Rs 5,203 lakh, and net profit increased 7.9% to Rs 2,223 lakh.
 
At Artemis Hospital, Gurgaon, the quarter saw average revenue per occupied bed (ARPOB) rise to Rs 84,100 from Rs 76,485, and revenue from operations jump 20.2% to Rs 26,092 lakh. Net profit for the hospital grew slightly by 1.8% to Rs 2,499 lakh. Bed occupancy remained steady at 62%, and revenue from overseas patients surged 34.9% to Rs 8,750 lakh, accounting for 34% of net revenue. The average length of patient stay was 3.6 days, compared to 3.7 days last year.
 
Consolidated nine-month results were equally strong. Revenue from operations increased 15.1% to Rs 80,202 lakh, EBITDA rose to Rs 15,862 lakh, and net profit jumped 23.9% to Rs 7,343 lakh. At Artemis Hospital, Gurgaon, nine-month revenue grew 17.5% to Rs 76,277 lakh, EBITDA climbed to Rs 15,981 lakh, and net profit reached Rs 8,200 lakh, up 13.6%. International patient revenue increased 32.2% to Rs 24,042 lakh, representing 32% of net revenue.
 
Commenting on the performance, Onkar Kanwar, Chairman of Artemis Medicare Services, said: "We are encouraged by our continued progress during the quarter, reflecting the sustained momentum achieved in FY26. In Q3, we recorded steady growth and strong operational performance, enabled by focused execution, effective cost management, and a continued emphasis on clinical quality and patient experience.
 
"Margins and profitability remained robust, supported by a favourable case and payor mix, increased international patient inflows, and ongoing efficiency initiatives. ARPOB stayed at healthy levels throughout the quarter, highlighting our leadership in high-acuity treatments and Medical Value Travel."
 
He added: "With respect to capacity expansion, the development of our Raipur facility is advancing as planned, with operations scheduled to commence in April 2026.
 
"As we move forward, our strategic focus remains on delivering sustainable, long-term growth through operational excellence, network expansion, and selective partnerships, while further strengthening Artemis’ reputation as a trusted and progressive healthcare platform in India.”

Artemis Medicare Services

First Published : February 03, 2026 12:00 am